IL33 and atherosclerosis: In Apolipoprotein E (ApoE) knock-out mice, IL-33 reduced the development of atherosclerosis via a Th1-to-Th2 switch23 and reducing accumulation of macrophage-derived foam cells in atherosclerotic plaques24.